IFP Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

IFP Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-261	Closed	-$56.9K	–	3190
2020 Q3	$35K	Buy	261 +40	+18%	+$4.25K	﹤0.01%	1417
2020 Q2	$21K	Buy	+221	New	+$18.4K	﹤0.01%	1558
2020 Q1	–	Sell	-831	Closed	-$53.3K	–	3100
2019 Q4	$61K	Buy	+831	New	+$50.4K	﹤0.01%	1178
2017 Q2	–	Sell	-500	Closed	-$7K	–	4288
2017 Q1	$7K	Hold	500	–	–	﹤0.01%	3169
2016 Q4	$6K	Hold	500	–	–	﹤0.01%	3236
2016 Q3	$8K	Buy	500 +300	+150%	+$5.42K	﹤0.01%	3003
2016 Q2	$2K	Buy	+200	New	+$2.5K	﹤0.01%	3534

IFP Advisors's MYOK Position: Q4 2020 in Review

IFP Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 261 shares — an estimated $56.9K sold.

IFP Advisors first reported a position in MYOK in Q2 2016 and held it in 7 quarters. The position peaked at $61K in Q4 2019. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

IFP Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
IFP Advisors sold 261 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $56.9K.
IFP Advisors first reported a position in MyoKardia, Inc. Common Stock in Q2 2016 and held it in 7 quarters.
IFP Advisors's MyoKardia, Inc. Common Stock position peaked at $61K in Q4 2019.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on IFP Advisors's 13F filing for Q4 2020, filed 25 Jan 2021.